CD2, primarily present on T cells and NK cells ... By disrupting the regulation of the PD-L1 protein by CMTM6, this activation enhances anti-tumor immunity, making cancer cells more vulnerable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback